{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:42:59Z","timestamp":1762854179656,"version":"build-2065373602"},"reference-count":61,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"am","delay-in-days":400,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.gofs.2019.03.009","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T12:29:19Z","timestamp":1552480159000},"page":"458-464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Suivi et conseils apr\u00e8s infection g\u00e9nitale haute. RPC infections g\u00e9nitales hautes CNGOF et SPILF"],"prefix":"10.1016","volume":"47","author":[{"given":"X.","family":"Ah-Kit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Hoarau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Graesslin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"Brun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2019.03.009_bib0310","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9378(75)90477-9","article-title":"Effect of acute pelvic inflammatory disease on fertility","volume":"121","author":"Westr\u00f6m","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.009_bib0315","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jgyn.2012.09.023","article-title":"Suivi et conseils apr\u00e8s infections g\u00e9nitales hautes","volume":"41","author":"Derniaux","year":"2012","journal-title":"J Gynecol Obstet Biol Reprod"},{"issue":"8 Suppl. 2","key":"10.1016\/j.gofs.2019.03.009_bib0320","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0368-2315(10)70026-0","article-title":"M\u00e9thodes et organisation","volume":"39","author":"Fauconnier","year":"2010","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.gofs.2019.03.009_bib0325","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/OLQ.0b013e31821f918c","article-title":"Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study","volume":"38","author":"Trent","year":"2011","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.gofs.2019.03.009_bib0330","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archpedi.162.11.1022","article-title":"Subsequent sexually transmitted infection after outpatient treatment of pelvic inflammatory disease","volume":"162","author":"Trent","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.gofs.2019.03.009_bib0335","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/sextrans-2011-050252","article-title":"Chlamydia trachomatis reinfections in a population-based cohort of women","volume":"89","author":"Liu","year":"2013","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.gofs.2019.03.009_bib0340","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/sti.2006.022053","article-title":"Incidence and reinfection rates of genital chlamydial infection among women aged 16\u201324 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group","volume":"83","author":"Scott Lamontagne","year":"2007","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.gofs.2019.03.009_bib0345","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.olq.0000135301.97350.84","article-title":"Prevention of gonorrhea and chlamydia through behavioral intervention: results of a two-year controlled randomized trial in minority women","volume":"31","author":"Shain","year":"2004","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.gofs.2019.03.009_bib0350","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/AOG.0b013e318177143a","article-title":"Preventing recurrent sexually transmitted diseases in minority adolescents: a randomized controlled trial","volume":"111","author":"Thurman","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.009_bib0355","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/01.olq.0000143083.38684.9d","article-title":"Comparison of methods to increase repeat testing in persons treated for gonorrhea and\/or chlamydia at public sexually transmitted disease clinics","volume":"31","author":"Malotte","year":"2004","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.gofs.2019.03.009_bib0360","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jemermed.2014.06.022","article-title":"Adolescent women with sexually transmitted infections: who gets lost to follow-up?","volume":"47","author":"Krivochenitser","year":"2014","journal-title":"J Emerg Med"},{"key":"10.1016\/j.gofs.2019.03.009_bib0365","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.annemergmed.2015.10.022","article-title":"Improving adolescent pelvic inflammatory disease follow-up from the emergency department: randomized controlled trial with text messages","volume":"67","author":"Wolff","year":"2016","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.gofs.2019.03.009_bib0370","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1067\/mob.2002.121625","article-title":"Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomized trial","volume":"186","author":"Ness","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.009_bib0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.05.021","article-title":"Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease?","volume":"198","author":"Trautmann","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.009_bib0380","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/infdis\/168.4.969","article-title":"Pelvic inflammatory disease: meta-analysis of antimicrobial regimen efficacy","volume":"168","author":"Walker","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.009_bib0385","first-page":"1606","article-title":"Pelvic inflammatory disease","volume":"2013","author":"Ross","year":"2013","journal-title":"BMJ Clin Evid"},{"key":"10.1016\/j.gofs.2019.03.009_bib0390","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/OLQ.0b013e3181a2a933","article-title":"Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature","volume":"36","author":"Hosenfeld","year":"2009","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.gofs.2019.03.009_bib0395","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/jdv.13850","article-title":"Background review for the 2016 European guideline on Mycoplasma genitalium infections","volume":"30","author":"Jensen","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"suppl. 2","key":"10.1016\/j.gofs.2019.03.009_bib0400","doi-asserted-by":"crossref","first-page":"S389","DOI":"10.1093\/infdis\/jix198","article-title":"Mycoplasma genitalium in women: current knowledge and research priorities for this recently emerged pathogen","volume":"216","author":"Wiesenfeld","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.gofs.2019.03.009_bib0405","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1046\/j.1469-0705.1995.06060430.x","article-title":"Transvaginal sonography in suspected pelvic inflammatory disease: suspected pelvic inflammatory disease","volume":"6","author":"Taipale","year":"1995","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.009_bib0410","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1469-0705.1998.12010056.x","article-title":"Transvaginal sonographic markers of tubal inflammatory disease: markers of tubal inflammatory disease","volume":"12","author":"Timor-Tritsch","year":"1998","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.009_bib0415","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s004040050123","article-title":"A study of second-look laparoscopy after acute salpingitis","volume":"258","author":"Gerber","year":"1996","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.gofs.2019.03.009_bib0420","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2105\/AJPH.94.8.1327","article-title":"Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease","volume":"94","author":"Ness","year":"2004","journal-title":"Am J Public Health"},{"key":"10.1016\/j.gofs.2019.03.009_bib0425","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1471-0528.1986.tb08036.x","article-title":"Oral contraceptive use modifies the manifestations of pelvic inflammatory disease","volume":"93","author":"Wolner-Hanssen","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.gofs.2019.03.009_bib0430","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1067\/mob.2001.115114","article-title":"Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study","volume":"185","author":"Ness","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.009_bib0435","first-page":"219","article-title":"Effect of pelvic inflammatory disease on fertility","volume":"8","author":"Westrom","year":"1995","journal-title":"Venereol Off Publ Natl Venereol Counc Aust"},{"key":"10.1016\/j.gofs.2019.03.009_bib0440","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0140-6736(92)91904-M","article-title":"Intrauterine devices and pelvic inflammatory disease: an international perspective","volume":"339","author":"Farley","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.gofs.2019.03.009_bib0445","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(97)09086-7","article-title":"Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices","volume":"351","author":"Walsh","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.gofs.2019.03.009_bib0450","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(00)02699-4","article-title":"Intrauterine device and upper genital tract infection","volume":"356","author":"Grimes","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.gofs.2019.03.009_bib0455","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.contraception.2005.08.007","article-title":"Dose insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review","volume":"73","author":"Mohllajee","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2019.03.009_bib0460","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/AOG.0b013e318273364c","article-title":"Neisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease","volume":"120","author":"Sufrin","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.009_bib0465","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1089\/jwh.2015.5190","article-title":"Positive testing for Neisseria gonorrhoeae and Chlamydia trachomatis and the risk of pelvic inflammatory disease in IUD users","volume":"24","author":"Birgisson","year":"2015","journal-title":"J Womens Health"},{"key":"10.1016\/j.gofs.2019.03.009_bib0470","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.whi.2014.09.006","article-title":"Same-day intrauterine device placement is rarely complicated by pelvic infection","volume":"25","author":"Papic","year":"2015","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.gofs.2019.03.009_bib0475","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.contraception.2013.11.011","article-title":"Worldwide use of intrauterine contraception","volume":"89","author":"Buhling","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2019.03.009_bib0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.05.017","article-title":"A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement","volume":"215","author":"Turok","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.009_bib0485","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00006250-199102000-00019","article-title":"Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years\u2019 comparative experience of levonorgestrel- and copper-releasing intrauterine devices","volume":"77","author":"Toivonen","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.009_bib0490","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0015-0282(16)56455-3","article-title":"Health during prolonged use of levonorgestrel 20 micrograms\/d and the copper T Cu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR)","volume":"61","author":"Sivin","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2019.03.009_bib0495","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/00016340802707473","article-title":"Infection risk and intrauterine devices","volume":"88","author":"Mart\u00ednez","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"year":"2018","series-title":"R\u00e9\u00e9valuation de la strat\u00e9gie de d\u00e9pistage des infections \u00e0 Chlamydia trachomatis","author":"Haute Autorit\u00e9 de sant\u00e9","key":"10.1016\/j.gofs.2019.03.009_bib0500"},{"year":"2013","series-title":"Contraception chez l\u2019homme et chez la femme","author":"Haute Autorit\u00e9 de sant\u00e9","key":"10.1016\/j.gofs.2019.03.009_bib0505"},{"year":"2005","series-title":"Crit\u00e8re de recevabilit\u00e9 pour l\u2019adoption et l\u2019utilisation des m\u00e9thodes contraceptives","author":"Organisation mondiale de la sant\u00e9","key":"10.1016\/j.gofs.2019.03.009_bib0510"},{"key":"10.1016\/j.gofs.2019.03.009_bib0515","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archpediatrics.2010.256","article-title":"Adverse adolescent reproductive health outcomes after pelvic inflammatory disease","volume":"165","author":"Trent","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.gofs.2019.03.009_bib0520","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/OLQ.0b013e3181557c25","article-title":"Chlamydia Antibodies, Chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) Study","volume":"35","author":"Ness","year":"2008","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.gofs.2019.03.009_bib0525","first-page":"12","article-title":"Infertility: a global perspective. The role of pelvic infection","volume":"3","author":"Sciarra","year":"1994","journal-title":"ORGYN"},{"key":"10.1016\/j.gofs.2019.03.009_bib0530","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1155\/S106474499900023X","article-title":"Infertility following pelvic inflammatory disease","volume":"7","author":"Pavletic","year":"1999","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.009_bib0535","first-page":"934","article-title":"Lower quality of life among women with chronic pelvic pain after pelvic inflammatory disease","volume":"102","author":"Haggerty","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2019.03.009_bib0540","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00423-015-1316-9","article-title":"The efficacy of adhesiolysis on chronic abdominal pain: a systematic review","volume":"400","author":"Gerner-Rasmussen","year":"2015","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.gofs.2019.03.009_bib0545","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00464-002-8845-3","article-title":"Results after laparoscopic lysis of adhesions and placements of seprafilm for intractable abdominal pain","volume":"17","author":"Khaitan","year":"2003","journal-title":"Surg Endosc"},{"key":"10.1016\/j.gofs.2019.03.009_bib0550","first-page":"5","article-title":"Abdominal adhesions: a practical review of an often overlooked entity","volume":"19","author":"Tabibian","year":"2017","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.gofs.2019.03.009_bib0555","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00007435-199207000-00001","article-title":"Pelvic inflammatory disease and fertility: a cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results","volume":"19","author":"Westr\u00f6m","year":"1992","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.gofs.2019.03.009_bib0560","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00007435-199609000-00007","article-title":"Decreasing incidences of gonorrhea- and chlamydia-associated acute pelvic inflammatory disease: a 25-year study from an urban area of central Sweden","volume":"23","author":"Kamwendo","year":"1996","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.gofs.2019.03.009_bib0565","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","article-title":"Possible role of ovarian epithelial inflammation in ovarian cancer","volume":"91","author":"Ness","year":"1999","journal-title":"J Nat Cancer Inst"},{"key":"10.1016\/j.gofs.2019.03.009_bib0570","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/ijgc-00009577-200807000-00001","article-title":"Inflammation: its role and interplay in the development of with special focus on gynecological malignancies","volume":"18","author":"Goswani","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gofs.2019.03.009_bib0575","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ijc.23017","article-title":"Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer","volume":"122","author":"Merritt","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gofs.2019.03.009_bib0580","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S1470-2045(11)70165-6","article-title":"Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study","volume":"12","author":"Lin","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gofs.2019.03.009_bib0585","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1186\/s12885-016-2857-1","article-title":"Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort study","volume":"16","author":"Shen","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gofs.2019.03.009_bib0590","first-page":"1459","article-title":"Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors","volume":"24","author":"Rasmussen","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.gofs.2019.03.009_bib0595","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ygyno.2016.08.318","article-title":"Increased risk of borderline ovarian tumors in women with a history of pelvic inflammatory disease: a nationwide population-based cohort study","volume":"143","author":"Rasmussen","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gofs.2019.03.009_bib0600","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1158\/1055-9965.EPI-16-0459","article-title":"Is pelvic inflammatory disease a risk factor for ovarian cancer?","volume":"26","author":"Rasmussen","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.gofs.2019.03.009_bib0605","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.canep.2018.05.011","article-title":"Risk of high-grade serous ovarian cancer associated with pelvic inflammatory disease, parity and breast cancer","volume":"55","author":"Stewart","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.gofs.2019.03.009_bib0305","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/0167482X.2015.1124852","article-title":"Risk of psychiatric disorders following pelvic inflammatory disease: a nationwide population-based retrospective cohort study","volume":"37","author":"Shen","year":"2016","journal-title":"J Psychosom Obstet Gynecol"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718919301126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718919301126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:38:48Z","timestamp":1762853928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718919301126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2468718919301126"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2019.03.009","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suivi et conseils apr\u00e8s infection g\u00e9nitale haute. RPC infections g\u00e9nitales hautes CNGOF et SPILF","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2019.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 CNGOF and SPILF. Published by Elsevier Masson Sas. All rights reserved.","name":"copyright","label":"Copyright"}]}}